378 related articles for article (PubMed ID: 14673473)
41. Selective silencing of a mutant transthyretin allele by small interfering RNAs.
Kurosawa T; Igarashi S; Nishizawa M; Onodera O
Biochem Biophys Res Commun; 2005 Nov; 337(3):1012-8. PubMed ID: 16225852
[TBL] [Abstract][Full Text] [Related]
42. Multi-elemental analysis of serum and amyloid fibrils in familial amyloid polyneuropathy patients.
Susuki S; Ando Y; Sato T; Nishiyama M; Miyata M; Suico MA; Shuto T; Kai H
Amyloid; 2008 Jun; 15(2):108-16. PubMed ID: 18484337
[TBL] [Abstract][Full Text] [Related]
43. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients.
Cappellari M; Cavallaro T; Ferrarini M; Cabrini I; Taioli F; Ferrari S; Merlini G; Obici L; Briani C; Fabrizi GM
J Peripher Nerv Syst; 2011 Jun; 16(2):119-29. PubMed ID: 21692911
[TBL] [Abstract][Full Text] [Related]
44. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
45. Clinical features of TTR-FAP in Portugal.
Conceição I
Amyloid; 2012 Jun; 19 Suppl 1():71-2. PubMed ID: 22480206
[TBL] [Abstract][Full Text] [Related]
46. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
[TBL] [Abstract][Full Text] [Related]
47. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
Hou X; Aguilar MI; Small DH
FEBS J; 2007 Apr; 274(7):1637-50. PubMed ID: 17381508
[TBL] [Abstract][Full Text] [Related]
48. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus.
Dardiotis E; Koutsou P; Papanicolaou EZ; Vonta I; Kladi A; Vassilopoulos D; Hadjigeorgiou G; Christodoulou K; Kyriakides T
Amyloid; 2009 Mar; 16(1):32-7. PubMed ID: 19291512
[TBL] [Abstract][Full Text] [Related]
49. Chapter 17: Transthyretin: an enhancer of nerve regeneration.
Fleming CE; Mar FM; Franquinho F; Sousa MM
Int Rev Neurobiol; 2009; 87():337-46. PubMed ID: 19682646
[TBL] [Abstract][Full Text] [Related]
50. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
Ikeda K; Kano O; Ito H; Kawase Y; Iwamoto K; Sato R; Sekine T; Nagata R; Nakamura Y; Hirayama T; Iwasaki Y
Neurology; 2008 Apr; 70(17):1576; author reply 1576-7. PubMed ID: 18427077
[No Abstract] [Full Text] [Related]
51. Regional difference and similarity of familial amyloidosis with polyneuropathy in France.
Adams D; Lozeron P; Theaudin M; Mincheva Z; Cauquil C; Adam C; Signate A; Vial C; Maisonobe T; Delmont E; Franques J; Vallat JM; Sole G; Pereon Y; Lacour A; Echaniz-Laguna A; Misrahi M; Lacroix C;
Amyloid; 2012 Jun; 19 Suppl 1():61-4. PubMed ID: 22620968
[TBL] [Abstract][Full Text] [Related]
52. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
[TBL] [Abstract][Full Text] [Related]
53. Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene.
Augustin S; Llige D; Andreu A; González A; Genescà J
Eur J Clin Invest; 2007 Aug; 37(8):673-8. PubMed ID: 17635579
[TBL] [Abstract][Full Text] [Related]
54. Regional differences and similarities of FAP in Sweden.
Hellman U; Suhr O
Amyloid; 2012 Jun; 19 Suppl 1():53-4. PubMed ID: 22468675
[TBL] [Abstract][Full Text] [Related]
55. Transthyretin is not expressed by dorsal root ganglia cells.
Sousa MM; Saraiva MJ
Exp Neurol; 2008 Dec; 214(2):362-5. PubMed ID: 18835560
[TBL] [Abstract][Full Text] [Related]
56. Transthyretin familial amyloid polyneuropathy.
Planté-Bordeneuve V; Kerschen P
Handb Clin Neurol; 2013; 115():643-58. PubMed ID: 23931808
[TBL] [Abstract][Full Text] [Related]
57. Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.
Leibou L; Frand J; Sadeh M; Lossos A; Kremer E; Livneh A; Yarnitsky D; Herman O; Dabby R
Isr Med Assoc J; 2012 Nov; 14(11):662-5. PubMed ID: 23240369
[TBL] [Abstract][Full Text] [Related]
58. [Pathogenesis and therapy for transthyretin related amyloidosis].
Ando Y; Jono H
Rinsho Byori; 2008 Feb; 56(2):114-20. PubMed ID: 18402051
[TBL] [Abstract][Full Text] [Related]
59. Most recent common ancestor of TTR Val30Met mutation in Italian population and its potential role in genotype-phenotype correlation.
Iorio A; De Angelis F; Di Girolamo M; Luigetti M; Pradotto L; Mauro A; Manfellotto D; Fuciarelli M; Polimanti R
Amyloid; 2015; 22(2):73-8. PubMed ID: 25510352
[TBL] [Abstract][Full Text] [Related]
60. [A sporadic case of late-onset familial amyloid polyneuropathy type I (transthyretin Met 30-associated familial amyloid polyneuropathy) inborn habitant of Ehime prefecture].
Harada T; Ishizaki F; Togo M; Yamashita H; Nitta K; Date Y; Nakazato M; Yamamura Y; Nakamura S
No To Shinkei; 2002 Jul; 54(7):615-9. PubMed ID: 12187722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
